Merck and Moderna Report Late Stage Success for Personalized mRNA Cancer Vaccine

By Elaine Chen · STAT News · 2026-08-19

STAT News reports that Merck and Moderna have achieved a significant milestone in oncology by demonstrating the efficacy of a personalized mRNA cancer vaccine in a randomized late-stage clinical trial. This development represents the first time a pharmaceutical partnership has pr

STAT News reports that Merck and Moderna have achieved a significant milestone in oncology by demonstrating the efficacy of a personalized mRNA cancer vaccine in a randomized late-stage clinical trial. This development represents the first time a pharmaceutical partnership has pr